LATEST
EQT agreed to acquire CleanawayNavigator Gas / Navigator HoldingsAlcoa / AliGroupInternational Seaways agreed to acquire BrutonBoston Crest PVT / LQR HouseBrady acquired Productivity Solutions and Services businessJMSB / EFSIVista Equity Partners / PKI Business UnitBluegem Capital Partners / Rispo GroupApax Partners agreed to acquire OdidoGTCR agreed to acquire CCC Intelligent SolutionsEQT agreed to acquire Stockbridge
Open App
Agreement signedPublished 19 May 2025

Regeneron Pharmaceuticals, Inc. /
23andMe

Regeneron Pharmaceuticals, Inc. signed an agreement for 23andMe.

Buy side: Regeneron Pharmaceuticals, Inc.
Buy sideRegeneron Pharmaceuticals, Inc.
Target: 23andMe
Target23andMe
Source · 19 May 2025Source-verified
See the source
Buy side: Regeneron Pharmaceuticals, Inc.
Buy sideRegeneron Pharmaceuticals, Inc.
Target: 23andMe
Target23andMe
01 / BuyerRegeneron Pharmaceuticals, Inc.
02 / Target23andMe
Source-verified
01

What happened

The deal for 23andMe is signed, with Regeneron Pharmaceuticals, Inc. as the buyer, at a stated price of $256.0 million.

The filing from 23andMe Holding Co. is dated May 19, 2025.

02

The source

Everything on this page comes from the source below.

01
Source · Original source

Regeneron Pharmaceuticals, Inc. signed an agreement for 23andMe.

This document is the source for the companies, stage, figure and people on this page.

Source-verified
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Announced

    The source this page is built from.

    Source-verified

  2. Published by the source

    The source this page is built from.

    Source-verified

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request an inviteAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.